Gary Zieziula
Direttore/Membro del Consiglio presso INNOVENT BIOLOGICS, INC.
Patrimonio netto: 23 851 $ in data 30/04/2024
Profilo
Gary J.
Zieziula currently works at Innovent Biologics, Inc., as Independent Non-Executive Director from 2022.
Mr. Zieziula also formerly worked at EMD Serono, Inc., as President & Managing Director, Bristol Myers Squibb Co., as VP-Sales & Cardiovascular Metabolic Products, Merck & Co., Inc., as Vice President-Sales, and AMAG Pharmaceuticals, Inc., as Chief Commercial Officer & Executive VP from 2010 to 2011.
Mr. Zieziula received his Masters Business Admin degree in 1983 from Canisius College and undergraduate degree in 1976 from State University of New York at Buffalo.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
INNOVENT BIOLOGICS, INC.
0.00% | 22/03/2024 | 4 877 ( 0.00% ) | 23 851 $ | 30/04/2024 |
Posizioni attive di Gary Zieziula
| Società | Posizione | Inizio |
|---|---|---|
| INNOVENT BIOLOGICS, INC. | Direttore/Membro del Consiglio | 31/05/2022 |
Precedenti posizioni note di Gary Zieziula
| Società | Posizione | Fine |
|---|---|---|
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Presidente | 01/09/2018 |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 04/11/2011 |
| MERCK & CO., INC. | Vendite & Marketing | - |
| BRISTOL-MYERS SQUIBB COMPANY | Vendite & Marketing | - |
Formazione di Gary Zieziula
| Canisius College | Masters Business Admin |
| State University of New York at Buffalo | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MERCK & CO., INC. | Health Technology |
| INNOVENT BIOLOGICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
- Borsa valori
- Insiders
- Gary Zieziula
